MARSHALL WACE, LLP: CVS position timeline
Available 13F reports, 13D and 13G stakes and each Form 3, 4 and 5 line of MARSHALL WACE, LLP on CVS, newest first. How the timeline and the estimate are built.
MARSHALL WACE, LLP held 325,000 CVS shares at 2026-06-30 per its 13F-HR filed 2026-08-13.
the latest 13F is the newest step
- period ended2026-06-3013F 325,000 sharesChange vs previous 13F -482,534 shares
0.03% of the 13F portfolio, value $33,621,250.
13F-HR 0001318757-26-000010 filed by MARSHALL WACE, LLP
Filed (acceptance time not in the bulk data set), ingestedAcceptance time not in the bulk data set (spec §4.2).
- period ended2026-03-3113F 807,534 sharesChange vs previous 13F +792,090 shares
0.06% of the 13F portfolio, value $57,997,092.
13F-HR 0001318757-26-000005 filed by MARSHALL WACE, LLP
Filed (acceptance time not in the bulk data set), ingestedAcceptance time not in the bulk data set (spec §4.2).
- period ended2025-12-3113F 15,444 sharesChange vs previous 13F -3,649,256 shares
<0.01% of the 13F portfolio, value $1,225,636.
13F-HR 0001318757-26-000003 filed by MARSHALL WACE, LLP
Filed (acceptance time not in the bulk data set), ingestedAcceptance time not in the bulk data set (spec §4.2).
- period ended2025-09-3013F 3,664,700 sharesChange vs previous 13F +1,930,505 shares
0.3% of the 13F portfolio, value $276,281,735.
13F-HR 0001318757-25-000046 filed by MARSHALL WACE, LLP
Filed (acceptance time not in the bulk data set), ingestedAcceptance time not in the bulk data set (spec §4.2).
- period ended2025-06-3013F 1,734,195 sharesChange vs previous 13F -1,992,101 shares
0.14% of the 13F portfolio, value $119,624,771.
13F-HR 0001318757-25-000034 filed by MARSHALL WACE, LLP
Filed (acceptance time not in the bulk data set), ingestedAcceptance time not in the bulk data set (spec §4.2).
- period ended2025-03-3113F 3,726,296 sharesChange vs previous 13F +3,041,644 shares
0.34% of the 13F portfolio, value $252,456,557.
13F-HR 0001318757-25-000023 filed by MARSHALL WACE, LLP
Filed (acceptance time not in the bulk data set), ingestedAcceptance time not in the bulk data set (spec §4.2).
- period ended2024-12-3113F 684,652 sharesChange vs previous 13F -771,264 shares
0.04% of the 13F portfolio, value $30,734,029.
13F-HR 0002048047-25-000005 filed by MARSHALL WACE, LLP
Filed (acceptance time not in the bulk data set), ingestedAcceptance time not in the bulk data set (spec §4.2).
- period ended2024-09-3013F 1,455,916 sharesChange vs previous 13F not available
0.12% of the 13F portfolio, value $91,547,998.
13F-HR 0001318757-24-000018 filed by MARSHALL WACE, LLP
Filed (acceptance time not in the bulk data set), ingestedAcceptance time not in the bulk data set (spec §4.2).